The announced price for alirocumab, the first PCSK9 inhibitor approved for use in the US, was the top story in managed care this week. Also, HHS announced $100 million available to combat substance abuse, and Medicare and Medicaid turn 50 years old.
The first PCSK9 inhibitor to combat bad cholesterol was approved for use in the US, and this week Sanofi and Regeneron set the wholesale price at $40 a day, which is well above what analysts had predicted. It is expected that payers, despite discounts, will strictly limit who gets the drug. A competitor, Amgen's evolocumab, may be joining the market by the end of the month.
Researchers determined that patients who receive a high number of prescriptions upon being discharged from the hospital are more likely to be readmitted within 30 days. Those who are readmitted are more like to be younger, African American, and have health problems such as heart disease, chronic obstructive pulmonary disease, diabetes, or metastatic cancer.
The government made a large number of funding available this week. HHS made $100 million in new funds available to combat substance abuse with a special focus on fighting opioid addiction. Plus, the Office of the National Coordinator announced it will award $38 million to 20 organizations to promote national efforts for better care, smarter spending, and healthier people.
And this week marked the 50th birthday of Medicare and Medicaid, the 2 largest healthcare payers in the country. The first Medicare recipient was former President Harry S. Truman, who received his card from President Lyndon B. Johnson at the signing ceremony in 1965. Currently, more than 55 million Americans are covered by Medicare.
Fragmented Payer System, Vulnerable Supply Chain Among Threats to Accessing Essential Medicines
March 13th 2024During a session of the 2024 V-BID Summit, panelists Stacie Dusetzina, PhD, and Inma Hernandez, PharmD, PhD, discussed how access to essential medications is curtailed not just by the longstanding complexities of insurance design but also by emerging threats such as supply chain weaknesses and cyberattacks.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
President Biden will preview his plan to more than double the size of Medicare’s new drug price negotiation program in the upcoming State of the Union address; Mexicans and Central Americans were most affected by the pandemic in terms of all-cause mortality; two Alabama fertility clinics said they expect to resume in vitro fertilization (IVF) services after a bill was passed to protect doctors.
Read More